UPDATE: ‘Instagram surpasses 2 billion monthly users while powering through a year of turmoil’ -CNBC

https://www.cnbc.com/2021/12/14/instagram-surpasses-2-billion-monthly-users.html?__source=sharebar|twitter&par=sharebar

byBenzinga Newsdesk

December 14, 2021

1 minute read

https://www.cnbc.com/2021/12/14/instagram-surpasses-2-billion-monthly-users.html?__source=sharebar|twitter&par=sharebar

US Stocks Mixed; Dow Rises Over 100 Points

By Lisa Levin

October 10, 9:57 AM

U.S. stocks traded mixed this morning, with the Dow Jones gaining more than 100 points on Monday.

ACMR

News

Atlas Crest Investment Corp. II Files Preliminary Proxy Statement To Obtain Stockholder Approval For Early Liquidation

By Benzinga Newsdesk

October 25, 5:26 PM

Atlas Crest Investment Corp. II (NYSE:ACII, ", ACII", , or the ", Company", )))) announced today that it has filed a preliminary proxy statement to seek stockholder approval to adopt amendments to its

ACII

News

Novartis’ Sandoz Unit Extended Collaboration Agreement to with Ares Genetics to Drive Cutting-edge Digital Solutions in Global Fight Against Antimicrobial Resistance

By Charles Gross

April 6, 5:42 AM

Sandoz today announces the extension and expansion until January 31, 2025 of its strategic collaboration agreement with Ares Genetics (Ares), aimed at driving cutting-edge digital solutions in the global fight against antimicrobial resistance (AMR).

NVS

Mizuho Maintains Neutral on USA Compression Partners, Raises Price Target to $19

By Benzinga Newsdesk

November 8, 10:50 AM

Mizuho analyst Gabriel Moreen maintains USA Compression Partners (NYSE:USAC) with a Neutral and raises the price target from $18 to $19.

USAC

UPDATE: ‘Instagram surpasses 2 billion monthly users while powering through a year of turmoil’ -CNBC

Related Posts

US Stocks Mixed; Dow Rises Over 100 Points

Atlas Crest Investment Corp. II Files Preliminary Proxy Statement To Obtain Stockholder Approval For Early Liquidation

Novartis’ Sandoz Unit Extended Collaboration Agreement to with Ares Genetics to Drive Cutting-edge Digital Solutions in Global Fight Against Antimicrobial Resistance

Mizuho Maintains Neutral on USA Compression Partners, Raises Price Target to $19